CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Ketamine-Morphine +1 moredrug
Likely dose
Ketamine-Morphine 0.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06021717
NCT06021717Phase 4Completed

PCA Ketamine-Morphine Versus PCA Morphine as Post-Operative Analgesia in Colorectal Surgery

Universiti Kebangsaan Malaysia Medical Centre·interventional·Posted Sep 1, 2023·Updated Sep 1, 2023

In Brief

A Phase 4 clinical trial evaluating Ketamine-Morphine and Morphine for Ketamine and Morphine. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to compare the effectiveness of PCA ketamine-morphine versus conventional PCA morphine in postoperative patients undergoing elective laparotomy colorectal surgery under general anaesthesia. The specific objectives are: 1. To compare the post-operative analgesic requirement with PCA ketamine-morphine in comparison with PCA morphine. 2. To compare the postoperative pain scores between PCA ketamine-morphine and PCA morphine. 3. To assess patients' overall satisfaction with PCA ketamine-morphine in comparison with PCA morphine. 4. To study the incidence of side effects of PCA ketamine-morphine in comparison with PCA morphine. Participants will be screened and recruited at pre-anaesthetic clinic (PAC). Those who consented will be taught to use PCA machine and the potential side effects of the study drugs. They will be randomly allocated into either Group A or Group B by computer generated randomization a day before planned surgery. Researchers will compare Group A and Group B to see post-operative pain scores, patients' overall satisfaction and any incidence of side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKetamine, Morphine
CountriesMalaysia
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedSep 1, 2023
Enrollment StartApr 5, 2018
Primary CompletionApr 4, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 2.8 years ago

Interventions

Ketamine-Morphinedrug

PCA ketamine (Ketamine HCl, Pfizer Inc., US) 0.5 mg plus morphine 0.5 mg ml-1 (ratio 1:1)

Morphinedrug

PCA morphine (Pfizer Inc., US) 1 mg ml-1